Mag-aso, Edsel S.

HRN: 19-68-13  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
RIFAXIMIN 200MG (TAB)
06/16/2022
06/23/2022
PO
200mg
BID
Imperical Escalation
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bloodstream    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: